Preparation and physicochemical stability of 50 mg/mL hydroxychloroquine oral suspension in SyrSpend(Ⓡ) SF PH4 (dry)

In the context of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, hydroxychloroquine has been proposed as a potential agent to treat patients with COVID-19 (coronavirus disease 2019) caused by SARS-CoV-2 infection. Older adults are more susceptible to COVID-19 and some pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Binson, Guillaume, Venisse, Nicolas, Sauvaget, Alexis, Bacle, Astrid, Lazaro, Pauline, Dupuis, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566679/
https://www.ncbi.nlm.nih.gov/pubmed/33075513
http://dx.doi.org/10.1016/j.ijantimicag.2020.106201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566679/
https://www.ncbi.nlm.nih.gov/pubmed/33075513
http://dx.doi.org/10.1016/j.ijantimicag.2020.106201

Ejemplares similares